Blog

Home » Blog

Urinary Incontinence Could Be Controlled by an Inflatable Penile Prosthesis

Due to the increasing numbers of radical prostatectomies performed for prostate cancer, a substantial and increasing number of patients suffer from postoperative urinary incontinence and erectile dysfunction (ED). An inflatable penile prosthesis is highly recommended as an initial procedure, especially in patients with the dual problems of ED and incontinence. Read the article.

Urinary Incontinence Could Be Controlled by an Inflatable Penile Prosthesis Read More »

Exercise, future anticancer therapy?

Several studies have demonstrated the benefits of exercise to improve the quality of life of people with cancer. But Dr. Fred Saad, urologist-oncologist and researcher at the University of Montreal Hospital Research Centre (CRCHUM), goes further. He believes that physical exercise has a direct effect on cancer, as effective as drugs, for treating patients with prostate cancer, even in advanced stages of the disease. Read the article.

Exercise, future anticancer therapy? Read More »

Technical improvements preserve potency after treatment for prostate cancer

A new form of highly personalised treatment for prostate cancer is showing promise in preserving potency. The new technique, termed “vessel sparing radiation”, preserved erectile function in 80 per cent of men at the five-year follow-up while maintaining excellent cure rates. Read the article.

Technical improvements preserve potency after treatment for prostate cancer Read More »

More Men With Early Prostate Cancer Are Choosing to Avoid Treatment

Seemingly overnight, treatment of men with early-stage prostate cancer has undergone a sea change. Five years ago, nearly all opted for surgery or radiation; now, nearly half are choosing no treatment at all. The approach is called active surveillance. It means their cancers are left alone but regularly monitored to be sure they are not growing. Just 10 percent to 15 percent of early-stage prostate cancer patients were being treated by active surveillance several years ago. Now, data from three independent sources consistently finds that 40 percent to 50 percent of them are making that choice. Read the article.

More Men With Early Prostate Cancer Are Choosing to Avoid Treatment Read More »

A Breakthrough Test for Prostate Cancer

Every four minutes, prostate cancer kills someone, somewhere around the world. Researchers at Cambridge Oncometrix, are developing a simple test that will detect the disease early. Dmitry Soloviev is one the scientists who’s helping to develop a test that can indicate the presence of cancer cells. Dr. Dmitry is the principal scientist at Oncometrix. Watch his video and learn more about this innovative test and how scientists are working to develop it further. Read the article.

A Breakthrough Test for Prostate Cancer Read More »

Video: “Imaging Tests”

July 2016 Awareness Night Imaging Tests Dr. Masoom Haider, MD, FRCPC Senior scientist, Physical Sciences, Odette Cancer Research Program Sunnybrook Research Institute Chief, Department of medical imaging, Sunnybrook Health Sciences Centre Professor, Department of medical imaging, University of Toronto Clinician scientist, Ontario Institute for Cancer Research   CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 44:07 minutes

Video: “Imaging Tests” Read More »

Questions to Ask Before Participating in a Prostate Cancer Clinical Trial

Several key questions that a participant will want answered before enrolling in a clinical trial are listed here. It is important that people learn as much as possible prior to entering a trial, and to thoroughly discuss the study with a doctor and with the study team. Read the article.

Questions to Ask Before Participating in a Prostate Cancer Clinical Trial Read More »

Extended lymph node dissection in robotic radical prostatectomy

Studies have shown that radical prostatectomy can improve progression-free and overall survival in patients with lymph node-positive prostate cancer. While this finding requires further validation, it does allow urologists to question the former treatment paradigm of aborting surgery when lymph node invasion from prostate cancer occurred, especially in patients with limited lymph node tumor infiltration. Studies show that intermediate- and high-risk patients should undergo extended pelvic lymph node dissection up to the common iliac arteries in order to improve nodal staging. Read the article.

Extended lymph node dissection in robotic radical prostatectomy Read More »

Scroll to Top